“This study is a critical step in unpicking the mysteries of cannabis as a source of medicine,” Dr. Wai Lui, the study’s lead researcher explained. “The cannabinoids examined have minimal, if any, hallucinogenic side effects, and their properties as anti-cancer agents are promising.”
Dr. Lui goes on to clarify that the cannabinoids that were studied “are able to interfere with the development of cancerous cells, stopping them in their tracks and preventing them from growing.”
Not only were the studied cannabinoids able to disrupt the cancerous cells growth, when used in “specific dosage patterns,” the marijuana-derivatives were actually able to “destroy cancer cells on their own.”
“Used in combination with existing treatment, we could discover some highly effective strategies for tackling cancer,” Dr. Lui proclaimed. “Significantly, these compounds are inexpensive to produce and making better use of their unique properties could result in much more cost effective anti-cancer drugs in future.”
The study in question was conducted at the St. George’s, University of London where six different cannabinoids including Cannabidiol (CBD) were tested on leukemia. The study’s researchers have vowed to continue examining the effects that cannabinoids have on cancer, and their effectiveness when combined with traditional forms of cancer treatments.
(c) The 420 Times – Read entire story here.